Whatever Happened to the New No-Patent COVID Vaccine Touted as a Global Game Changer?

August 31, 2022

(NPR) – Back in January, we told you about a different kind of COVID vaccine that had just been approved for use in India. The vaccine, called Corbevax, had some very attractive properties: It’s low-cost, easy to make using well-established biotech processes — and patent-free. The vaccine’s inventors were hoping it would help address questions of vaccine equity for countries that can’t afford to make or buy expensive vaccines like the ones sold by Pfizer and Moderna. It appears their strategy is working. Since Corbevax was authorized for use last December, Indian health authorities have administered quite a few doses. Here’s where things stood on August 10 when I spoke with the two scientists who invented it: Peter Hotez and Maria Elena Botazzi, co-directors of the Center for Vaccine Development at Texas Children’s Hospital. (Read More)